Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,397 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT03666000

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
  • Northside Hospital Cancer Institute Atlanta, Georgia, United States
  • University of Maryland Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT05091424

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • The James Cancer Hospital and Solove Research Institute Columbus, Ohio, United States
  • Uni of Texas - Md Anderson Cancer Center Houston, Texas, United States
View all 31 locations
View Trial Details
Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

NCT04269902

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 632 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07218341

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
  • Cancer Specialists, LLC Jacksonville, Florida, United States
  • Minnesota Oncology Hematology, P.A. Coon Rapids, Minnesota, United States
View all 50 locations
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 32 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

NCT07321652

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Jupiter Medical Center Jupiter, Florida, United States
  • Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
  • Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho, United States
View all 210 locations
View Trial Details
Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Hematology Oncology of Indiana Indianapolis, Indiana, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

NCT07520006

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Oncology Associates of Oregon Eugene, Oregon, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions